USP EP BP Medicine Kalasi 148408-66-6 Docetaxel trihydrate pochiza Khansa ya Chotupa
Zogulitsadzina | Docetaxel Trihydrate |
Mawu ofanana ndi mawu | (αR,βS) -β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -12b -(acetyloxy) -12-(benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13 ,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3) |
CAS No. | 148408-66-6 |
Maonekedwe | Ufa wa crystalline woyera mpaka woyera |
Molecular Formula | C43H53NO14.3 (H2O) |
Kulemera kwa Maselo | 861.94 |
Kugwiritsa ntchito | Gulu la Pharma kapena cholinga chofufuzira |
Kulongedza | Monga mwa pempho lanu |
Kusungirako | Sungani m'zotengera zolimba, zosagwira kuwala pamalo ozizira |
ZINTHU | MFUNDO | ZOTSATIRA |
Makhalidwe | A: ufa woyera mpaka woyera | Zimagwirizana |
B: Kusungunuka: Kusungunuka m'madzi, kusungunuka mu ethanol ndi acetone | Zimagwirizana | |
ZachindunjiRotation | ﹣38.5°~﹣41.5° | ﹣40 ° |
Chizindikiritso | 1.IR: Zomwezo kuti muwone zitsanzo | Zimagwirizana |
2.UV: λmax232nm | Zimagwirizana | |
| Zimagwirizana | |
| Zimagwirizana | |
Zonyansa | Zonyansa zonse: NMT 1.0% | 0.29% |
Zosafunika A: NMT 0.5% | 0.0551% | |
Zosafunika B: NMT 0.3% | 0.0470% | |
Zosafunika C: NMT 0.3% | 0.0535% | |
Chidetso china chilichonse: NMT 0.1% | 0.0702% | |
Madzi | 5.0% - 7.0% | 6.15% |
Zotsalira pakuyatsa | NMT 0.1% w/w | 0.03% |
Chitsulo cholemera | NMT 20ppm | Zimagwirizana |
Kuyesa | 97.5% ~ 102.0% | 99.7% |
Mapeto | Zimakumana ndi EP7.5. |
Zambiri Zamakampani
√ Kudziwa kwathunthu kwa Management layer mu otsatira fakitale ndi akatswiri aluso; √ Quality nthawi zonse timaganizira kwambiri, Olimba QC dongosolo; √ zaka 11 zokumana nazo zogulitsa kunja; √ Independent R&D labu; √ Misonkhano iwiri yosayinidwa yanthawi yayitali ya GMP; √ Zida zolemera zamafakitale ambiri opanda pake pazosintha makonda; √ Gulu logwira ntchito molimbika kwambiri lomwe lili ndi njira yosasinthika.Lembani uthenga wanu apa ndikutumiza kwa ife